Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • swNGS
    Member
    • Nov 2011
    • 83

    ECC vc non-ECC RAM for NGS Workstation

    Hi,

    I am in the process of spec'ing a workstation for processing human FASTQ resequencing data from GAII and MiSeq analysers. All pipelines will be alignment to reference genome and variant calling only (no denovo assembly). I think I'll be looking in the region of 32 GB memory.

    I've been looking at some of the Dell workstations, which all seem to use ECC ram as far as I can see. I understand that ECC ram produces less errors, but on the other hand is MUCH more expensive than non-ECC ram. Would it be a problem to not use non-ECC memory to reduce the cost ?

    Thanks,

    Chris
  • gringer
    David Eccles (gringer)
    • May 2011
    • 845

    #2
    ECC is insurance against future damage to your data and/or results. ECC ram will save you quite a bit in debugging time (i.e. debugging money) if sometime down the line there are a few errors that play an important role in the outcome of an analysis. Bad RAM is much more likely when there's more of it, which is part of the reason why ECC is used.

    Comment

    • swNGS
      Member
      • Nov 2011
      • 83

      #3
      Does anyone hav any real world examples of either scenario?
      Eg where using non-ECC memory has caused a problem?.
      In terms of scale I doubt I'll go over 32GB

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        Here's a post about where a flipped bit created a problem building a program:



        I remember reading another blog post that was more related to genomics that discussed a similar situation (which held up the release of their latest version of their program), but can't seem to find the post again. Maybe someone else on this forum also remembers....

        Comment

        • tonybolger
          Senior Member
          • Feb 2010
          • 156

          #5
          Originally posted by swNGS View Post
          I've been looking at some of the Dell workstations, which all seem to use ECC ram as far as I can see. I understand that ECC ram produces less errors, but on the other hand is MUCH more expensive than non-ECC ram. Would it be a problem to not use non-ECC memory to reduce the cost ?
          Annoyingly, ECC doesn't add _that_ much to the cost of the memory itself, especially for large sizes (right now, 8GB ECC registered is actually cheaper than 8GB non-ECC unregistered), but many machine vendors like to mark it up because they know you really want it. Plus the motherboards / CPUs which support it are more expensive (at least for intel).

          IMHO, ECC isn't optional, it's absolutely required for bioinformatics, where a single bit error is likely to go undetected and silently corrupt your results.

          But you're right, you'll pay a lot more for the machine with ECC vs one without, but you'll usually get a better tier of machine across the board.

          Comment

          • BaCh
            Member
            • May 2008
            • 81

            #6
            Originally posted by swNGS View Post
            Does anyone hav any real world examples of either scenario?
            Eg where using non-ECC memory has caused a problem?.
            Yes ... oh yes. Has cost me weeks of time and lots of nerves. I'll look for ECC on my next development machine.

            Here's an account of what happened:



            B.

            Comment

            • gringer
              David Eccles (gringer)
              • May 2011
              • 845

              #7
              I remember reading another blog post that was more related to genomics that discussed a similar situation (which held up the release of their latest version of their program), but can't seem to find the post again. Maybe someone else on this forum also remembers....
              MIRA, yes, that was it. Thanks.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              18 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              32 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              43 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              29 views
              0 reactions
              Last Post SEQadmin2  
              Working...